← Leaderboards
Hava Karsenty Avraham
Beth Israel Deaconess Medical Center
$3,719,280
Attributed
$3,719,280
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $378.3K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$3,719,280 · 5
By mechanism
R01$2,673,080 · 2
R21$560,200 · 2
K18$486,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Zhao-Yi Wang$2,879,953
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionBreast NeoplasmsTissue /Cell CultureImmunocytochemistryPhosphorylationDna DamageBiological Signal TransductionTranscription FactorHuman TissueClinical ResearchFlow CytometryWestern BlottingsBrca GeneNeoplastic CellPolymerase Chain ReactionCellsInheritedApoptosisInsightCell LineCancer-Predisposing GeneCell Growth RegulationGenesBreast
Grant awards (14)
BRCA1, Sporadic Breast Cancer and Aging Women$149,600
R21 · FY2010 · CA · contact PI
BRCA1, Sporadic Breast Cancer and Aging Women$149,600
R21 · FY2009 · CA · contact PI
Studies of a novel BRCA1 tricomplex in breast cancer$358,649
R01 · FY2007 · CA · contact PI
Studies of a novel BRCA1 tricomplex in breast cancer$369,361
R01 · FY2006 · CA · contact PI
Studies of a novel BRCA1 tricomplex in breast cancer$378,250
R01 · FY2005 · CA
Studies of a novel BRCA1 tricomplex in breast cancer$378,250
R01 · FY2004 · CA
Mammary Epithelial Development from Marrow Stem Cells$243,000
K18 · FY2004 · HL
Studies of a novel BRCA1 tricomplex in breast cancer$378,250
R01 · FY2003 · CA
Mammary Epithelial Development from Marrow Stem Cells$243,000
K18 · FY2003 · HL
CHK, NOVEL SIGNALING MOLECULE, IN BREAST CANCER$278,129
R01 · FY2002 · CA
CHK, NOVEL SIGNALING MOLECULE, IN BREAST CANCER$270,027
R01 · FY2001 · CA
REGULATION OF BRCA1 SIGNALING AND FUNCTION BY HEREGULIN$130,500
R21 · FY2001 · CA
CHK, NOVEL SIGNALING MOLECULE, IN BREAST CANCER$262,164
R01 · FY2000 · CA
REGULATION OF BRCA1 SIGNALING AND FUNCTION BY HEREGULIN$130,500
R21 · FY2000 · CA